Franco-Nevada: Q2 Earnings Insights
Franco-Nevada (NYSE:FNV) reported its Q2 earnings results on Wednesday, August 10, 2022 at 05:00 PM.
Here's what investors need to know about the announcement.
Franco-Nevada Q2 EPS $1.02 Beats $0.98 Estimate, Sales $352.30M Beat $345.29M Estimate
Franco-Nevada (NYSE:FNV) reported quarterly earnings of $1.02 per share which beat the analyst consensus estimate of $0.98 by 4.08 percent. This is a 6.25 percent increase over earnings of $0.96 per share from the same
Earnings Scheduled For August 10, 2022
Companies Reporting Before The Bell
• Wix.com (NASDAQ:WIX) is estimated to report earnings for its second quarter.
Earnings Outlook For Franco-Nevada
Franco-Nevada (NYSE:FNV) is set to give its latest quarterly earnings report on Wednesday, 2022-08-10. Here's what investors need to know before the announcement.
Analysts estimate that Franco-Nevada will report an earnings per share (EPS) of $0.98.
Keybanc Maintains Overweight on Franco-Nevada, Lowers Price Target to $143
Keybanc analyst Adam Josephson maintains Franco-Nevada (NYSE:FNV) with a Overweight and lowers the price target from $180 to $143.
Ominous Death Cross Forms On Franco-Nevada’s Chart
If history is any guide, there may be trouble ahead for shares of Franco-Nevada (NYSE:FNV). A so-called "death cross" has formed on its chart and, not surprisingly, this could be bearish for the stock.
$100 Invested In Franco-Nevada 10 Years Ago Would Be Worth This Much Today
Franco-Nevada (NYSE:FNV) has outperformed the market over the past 10 years by 1.03% on an annualized basis producing an average annual return of 11.53%. Currently, Franco-Nevada has a market capitalization of $26.35 billion.
Earnings Scheduled For May 4, 2022
Companies Reporting Before The Bell
• Seres Therapeutics (NASDAQ:MCRB) is estimated to report quarterly loss at $0.52 per share on revenue of $8.48 million.
Keybanc Maintains Overweight on Franco-Nevada, Raises Price Target to $180
Keybanc analyst Adam Josephson maintains Franco-Nevada (NYSE:FNV) with a Overweight and raises the price target from $150 to $180.